Medicine, Chinese traditional,Lipopolysaccharide,Nitric oxide,Nuclear factor-κB;,Mitogen-activated protein kinases,Tumor necrosis factor-α,Inflammation," /> Medicine, Chinese traditional,Lipopolysaccharide,Nitric oxide,Nuclear factor-κB;,Mitogen-activated protein kinases,Tumor necrosis factor-α,Inflammation,"/>
Journal of Integrative Medicine ›› 2017, Vol. 15 ›› Issue (4): 326-336.doi: 10.1016/S2095-4964(17)60350-9
• Research Article • Previous Articles
Byung Hyuk Hana,b, Yun Jung Leea,b, Jung Joo Yoona,b, Eun Sik Choia,b, Seung Namgunga,b, Xian Jun Jina,b, Da Hye Jeonga,b, Dae Gill Kanga,b
, Ho Sub Leea,b
| 1 Sharma JN, Al-Omran A, Pavathy SS.Role of nitric oxide in inflammatory diseases. 2 Yun HY, Dawson VL, Dawson TM.Neurobiology of nitric oxide. 3 Posadas I, Terencio MC, Guillén I, Ferrándiz ML, Coloma J, Payá M, Alcaraz MJ.Co-regulation between cyclooxygenase- 2 and inducible nitric oxide synthase expression in the time-course of murine inflammation. 4 Isomäki P, Punnonen J.Pro- and anti-inflammatory cytokines in rheumatoid arthritis. 5 Chen JW, Chen YH, Lin FY, Chen YL, Lin SJ. 6 Gloire G, Legrand-Poels S, Piette J.NF-κB activation by reactive oxygen species: fifteen years later. 7 Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA.Possible new role for NF-κB in the resolution of inflammation. 8 Hawiger J, Veach RA, Liu XY, Timmons S, Ballard DW.IκB kinase complex is an intracellular target for endotoxic lipopolysaccharide in human monocytic cells. 9 Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH.Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. 10 Christman JW, Lancaster LH, Blackwell TS.Nuclear factor κB: a pivotal role in the systemic inflammatory response syndrome and new target for therapy. 11 Guha M, Mackman N.LPS induction of gene expression in human monocytes. 12 Angel P, Karin M.The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. 13 Cobb MH.MAP kinase pathways. 14 Davis RJ.Signal transduction by the c-Jun N-terminal kinase. 15 Potapova O, Basu S, Mercola D, Holbrook NJ.Protective role for c-Jun in the cellular response to DNA damage. 16 Delgado M.Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in endotoxinactivated microglia. 17 Wallach D, Varfolomeev EE, Malinin NL, Glitsev YV, Kovalenko AV, Boldin MP.Tumor necrosis factor receptor and Fas signaling mechanisms. 18 Ettinger R, Mebius R, Browning JL, Michie SA, van Tuijl S, Kraal G, van Ewijk W, McDevitt HO. Effects of tumor necrosis factor and lymphotoxin on peripheral lymphoid tissue development. 19 Yoon HJ, Moon ME, Park HS, IM SY, Kim YH.Chitosan oligosaccharide (COS) inhibits LPS-induced inflammatory effects in RAW264.7 macrophage cells. 20 Hirano T, Matsuda T, Nakajima K.Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily. 21 Kim MC, Lee CH, Yook TH.Effects of anti-inflammatory and 22 Zeng H, Dou S, Zhao J, Fan S, Yuan X, Zhu S, Li L, Zhang W, Liu R.The inhibitory activities of the components of Huang-Lian-Jie-Du-Tang (HLJDT) on eicosanoid generation via lipoxygenase pathway. 23 Kim NK, Lee DH, Seo HS, Sun SH, Oh YL, Kim JE, Yoon IH, Seo ES, Shim GS, Zaslawski C.Hwangryunhaedoktang in adult patients with atopic dermatitis: a randomised, double-blind, placebo-controlled, two-centre trial—study protocol. 24 Seo CS, Kim OS, Kim JH, Shin HK.Simultaneous quantification and antiatherosclerosis effect of the traditional Korean medicine, Hwangryunhaedok-tang. 25 Gilroy DW, Colville-Nash PR.New insights into the role of COX 2 in inflammation. 26 Lin MW, Tsao LT, Chan LC, Chen YL, Huang LJ, Kuo SC, Tzeng CC, Lee MR, Wang JP.Inhibition of lipopolysaccharide-stimulated NO production by a novel synthetic compound CYL-4d in RAW264.7 macrophages involving the blockade of MEK4/JNK/AP-1 pathway. 27 Ahmad N, Chen LC, Gordon MA, Laskin JD, Laskin DL.Regulation of cyclooxygenase-2 by nitric oxide in activated hepatic macrophages during acute endotoxemia. 28 Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, Lee L, Isakson P.Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. 29 Xie QW, Kashiwabara Y, Nathan C.Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. 30 Brasier AR.The nuclear factor-κB-interleukin-6 signalling pathway mediating vascular inflammation. 31 Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: downregulation of COX-2 and iNOS through suppression of NF- κB activation. 32 Tsao LT, Tsai PS, Lin RH, Huang LJ, Kuo SC, Wang JP.Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase by phenolic (3E)-4-(2- hydroxyphenyl)but-3-en-2-one in RAW264.7 macrophages. 33 Zhang JM, An JX.Cytokines, inflammation and pain. 34 Aggarwal BB, Natarajan K.Tumor necrosis factor: developments during the last decade. |